VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SENS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SENSSenseonics Holdings, Inc.
$5.33$223M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

SENS logoSenseonics Holdings, Inc.(SENS)Earnings, Financials & Key Ratios

SENS•NASDAQ
$5.33
Price updated Jul 7, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDiabetes care and insulin delivery
AboutSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Show more
  • Revenue$35M+56.9%
  • EBITDA-$67M+8.9%
  • Net Income-$69M+12.1%
  • EPS (Diluted)-1.66+33.6%
  • Gross Margin44.71%+1785.0%
  • EBITDA Margin-189.54%+41.9%
  • Operating Margin-193.83%+41.8%
  • Net Margin-196.03%+44.0%
  • ROE-310.68%+62.0%

SENS Price & Volume

Senseonics Holdings, Inc. (SENS) stock price & volume — 10-year historical chart

Loading chart...

Accelerating Revenue Growth Faces Severe Liquidity Constraints

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Accelerating
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:High cash burn rate

Key Thesis Takeaways

  • Senseonics demonstrates significant top-line momentum with 87.2% year-over-year revenue growth in 2026Q1, yet the company remains hampered by a persistent operating deficit and a $1.0 billion accumulated deficit.
  • While the Eversense CGM system gains market traction, the firm's reliance on debt financing and high SG&A expenses of $30.2M per quarter creates a precarious financial profile.
  • Investors should monitor the company's ability to achieve manufacturing scale and operational profitability before the current $29.9M cash balance is exhausted.

Verdict Logic

the company's current cash runway is rapidly depleting, with cash reserves falling to $29.9M in 2026Q1 against a quarterly operating cash outflow of $32.0M.

SENS Growth Metrics

Senseonics Holdings, Inc. (SENS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years98.04%
5 Years48.1%
3 Years29.09%
TTM71.91%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-17.82%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM5.68%

Return on Capital

10 Years-255.02%
5 Years-64.28%
3 Years-74.06%
Last Year-83.59%

SENS Recent Earnings

Senseonics Holdings, Inc. (SENS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (8%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.71-3.6%
$0.69
Rev
$12M+19.1%
$10M
Q2 2026
Mar 2, 2026
Metric
Actual
Est
EPS
$0.46-7.0%
$0.43
Rev
$14M+0.4%
$14M
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$0.43-30.3%
$0.33
Rev
$8M-43.1%
$14M
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$0.40+0.0%
$0.40
Rev
$8M+37.8%
$6M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.71vs $0.69-3.6%
$12Mvs $10M+19.1%
Q2 2026Mar 2, 2026
$0.46vs $0.43-7.0%
$14Mvs $14M+0.4%
Q4 2025Nov 5, 2025
$0.43vs $0.33-30.3%
$8Mvs $14M-43.1%
Q3 2025Aug 6, 2025
$0.40vs $0.40+0.0%
$8Mvs $6M+37.8%
Based on last 12 quarters of dataView full earnings history →

Latest SENS News

Recent stock market news and headlines for Senseonics Holdings, Inc. (SENS)

Zacks Investment Research·Jun 29, 2026
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?

Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Peers Comparison

Key metrics vs top competitors for Senseonics Holdings, Inc. (SENS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
SENS logoSENSSenseonics Holdings, Inc.Current
$5.33$222.76M-3.2156.89%-196.03%-310.68%—
DXCM logoDXCMDexCom, Inc.
$73.57$28.39B35.2015.6%19.31%33.83%—
ABT logoABTAbbott Laboratories
$95.84$166.94B25.765.67%13.91%12.09%—
PODD logoPODDInsulet Corporation
$161.55$11.34B46.4230.73%10.44%21.38%—
TNDM logoTNDMTandem Diabetes Care, Inc.
$15.43$1.06B-5.087.93%-9.2%-68.29%—
GMED logoGMEDGlobus Medical, Inc.
$78.83$10.63B20.1116.65%18.92%13.04%—

Compare SENS vs Peers

Senseonics Holdings, Inc. (SENS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DXCM

Most directly comparable listed peer for SENS.

Scale Benchmark

vs LLY

Larger-name benchmark to compare SENS against a more recognizable public peer.

Peer Set

Compare Top 5

vs DXCM, ABT, PODD, TNDM

SENS SEC Filings & Documents

Senseonics Holdings, Inc. (SENS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Mar 1, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

Get notified when SENS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

SENS Frequently Asked Questions

Senseonics Holdings, Inc. (SENS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Senseonics Holdings, Inc.'s revenue?

Senseonics Holdings, Inc. (SENS) reported $40.7M in revenue for fiscal year 2025. This represents a 239376% increase from $0.0M in 2013.

How fast is Senseonics Holdings, Inc. growing?

Senseonics Holdings, Inc. (SENS) grew revenue by 56.9% over the past year. This is strong growth.

Is SENS profitable?

Senseonics Holdings, Inc. (SENS) reported a net loss of $87.2M for fiscal year 2025.

Dividend & Returns
What is SENS's return on equity?

Senseonics Holdings, Inc. (SENS) has a return on equity (ROE) of -310.7%. Negative ROE indicates the company is unprofitable.

What is Senseonics Holdings, Inc.'s free cash flow?

Senseonics Holdings, Inc. (SENS) had negative free cash flow of $75.9M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in SENS back in 2013?

Total return calculator · dividends reinvested · 13+ years of data

See returns →